Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06091670
Other study ID # ECaliskan1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 7, 2022
Est. completion date February 15, 2023

Study information

Verified date October 2023
Source Istanbul University - Cerrahpasa (IUC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study was to determine the genital hygiene practices of women in different regions of Turkey and the factors influencing these practices. It is a descriptive, cross-sectional study. The study was conducted according to the STROBE checklist.


Description:

The aim of this study was to determine the genital hygiene practices of women in different regions of Turkey and the factors influencing these practices. It is a descriptive, cross-sectional study. Data Collection Tools Data for the study was collected through the "Data Collection Form" and "Genital Hygiene Behaviors Inventory", created by the researchers by reviewing the literature (Karahan, 2017; Cankaya, 2013; Elzayat et al. 2017; Adam and Saadia, 2016; Akgul, 2019). Data collection form: A survey consisting of 13 questions about the age of the women, the amount of water consumed daily, the number of urinations, the genital infection status, and sexuality. Genital Hygiene Behaviors Inventory - GHBI: A scale, developed by Karahan (2017), and for which written permission for use was obtained, consisting of 23 items in total and 3 sub-dimensions: "genital hygiene behaviors", "menstrual habits" and "abnormal findings". Items 1-12 evaluate genital hygiene, items 13-20 evaluate menstrual hygiene, and items 21-23 evaluate the awareness of abnormal findings. Items 7, 14, 19, 20 and 23 of the scale are the reversed items and are reverse coded during the evaluation. A minimum total of 23 and a maximum total of 115 points can be obtained from the 5-point Likert-type scale, where "1" point means "I totally disagree" and "5" points means "I completely agree". Higher scale scores correspond to better genital hygiene behaviors. The study evaluating the development of the scale and its validity and reliability determined the Cronbach's Alpha coefficient as 0.80 (Karahan, 2017); our study's Cronbach's Alpha coefficient was 0.78. Data Collection The prepared data collection form and the scale were transferred to the computer environment and delivered online to the women through the snowball sampling method. It took approximately 10 minutes for each participant to complete the data collection forms Data Analysis The data collected in the study was analyzed using the Statistical Package for the Social Sciences, version 25.0 (SPSS, v25.0) statistical analysis package program (IBM Company, Turkey). First the descriptive data of the study was analyzed. Mean, median, standard deviation, minimum and maximum values were calculated in the analysis of continuous data, and numbers and percentages were calculated in the analysis of categorical data. Next, non-parametric and parametric tests were used according to normality distributions. Pearson Chi-square test, Kruskal Wallis Test and Mann Whitney-U tests were used to analyze the data. A simple linear regression analysis model was used to determine the factors affecting genital hygiene behaviors. Statistical significance level was accepted as p<.05 at 95% confidence interval.


Recruitment information / eligibility

Status Completed
Enrollment 881
Est. completion date February 15, 2023
Est. primary completion date November 12, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Agreeing to participate in the study, - To speak and understand Turkish, - women Exclusion Criteria: - not being able to read and understand Turkish - dont want to participate the research

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
There is no intervention. The research is cross-sectional-descriptive type.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University - Cerrahpasa (IUC)

References & Publications (5)

Abdel-Aziz Elzayat M, Barnett-Vanes A, Dabour MF, Cheng F. Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt. BMJ Open. 2017 Mar 21;7(3):e013198. doi: 10.1136/bmjopen-2016-013198. — View Citation

Emiru T, Beyene G, Tsegaye W, Melaku S. Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia. BMC Res Notes. 2013 Jul 25;6:292. doi: 10.1186/1756-0500-6-292. — View Citation

Haider G, Zehra N, Munir AA, Haider A. Risk factors of urinary tract infection in pregnancy. J Pak Med Assoc. 2010 Mar;60(3):213-6. — View Citation

Minardi D, d'Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. Int J Gen Med. 2011;4:333-43. doi: 10.2147/IJGM.S11767. Epub 2011 Apr 19. — View Citation

Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am. 1997 Sep;11(3):719-33. doi: 10.1016/s0891-5520(05)70382-2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Genital Hygiene Behavior Inventory (GHBI) Likert type inventory consisting of 27 questions evaluating genital hygiene behaviors.Inventory was applied to all pregnant women participating in the study at the beginning and at the end of the study. 1 times
Primary Data collection form: This survey was created by the researchers according to the literature.6-9 The survey consisted of 13 questions about the sociodemographic features and the behaviors related genital tract infections. 1 times
See also
  Status Clinical Trial Phase
Recruiting NCT04495699 - Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
Terminated NCT05254808 - EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care Phase 3
Completed NCT03680612 - Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI Phase 2
Completed NCT03282006 - Treating Pyelonephritis an Urosepsis With Pivmecillinam Phase 4
Completed NCT03526484 - The Utility of Urinalysis Prior to In-Office Procedures N/A
Completed NCT05397782 - Effects of Flourish on Recurrent Urinary Tract Infection N/A
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03687255 - Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections Phase 3
Recruiting NCT05227937 - Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Completed NCT03131609 - Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department
Completed NCT01911143 - A Retrospective, Blinded Validation of a Host-response Based Diagnostics N/A
Completed NCT01333254 - A Trial of Different Methods for Bladder Drainage in Hip Surgery Patients N/A
Terminated NCT00594594 - Adjuntive Probiotic Therapy in Treating Urinary Tract Infections in Spinal Cord Injury Phase 1
Completed NCT00216853 - A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection N/A
Completed NCT00787085 - The Significance of Funguria in Hospitalized Patients N/A
Completed NCT05719753 - The Effectiveness of a Bacteriophobic Coating on Urinary Catheters N/A
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Not yet recruiting NCT05880329 - DIagnoSing Care hOme UTI Study
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine